Core Therapeutic Protocol
The foundation of our approach involves the precise intra-articular administration of umbilical cord-derived
mesenchymal stem cells (UC-MSCs) into the affected ankle joint. These cells are selected for their
well-documented immunomodulatory properties and chondrogenic potential. The administration is performed
under ultrasound guidance to ensure accurate placement within the joint space.
Following cellular administration, patients enter a structured rehabilitation phase. This phase integrates
progressive physical therapy protocols designed to protect the newly introduced cellular environment while
gradually restoring range of motion, strength, and proprioception. The physical therapy component is
individually calibrated based on the extent of cartilage damage and the patient's functional baseline.